|
|
 |
 |
| |
 Printable version |
Whole-body
18F-fluorodeoxyglucose positron emission tomography in digestive tract cancers (excluding endocrine tumours) |
Hépato-Gastro. Volume 17, Number 1, 11-9, janvier-février 2010, Mini-revue
|
 Résumé
Article gratuit
|
Author(s) : Jean-Philippe Vuillez |
Summary : PET-FDG scintigraphy clearly improves the management of digestive tract cancers, complementary to morphological imaging, leading to a significant impact on treatment and prognosis. Best indications are the diagnosis of disease extension of colorectal cancers (CRC), especially for liver metastatic resecability, localization of suspected recurrences when CEA is raising in blood, and diagnosis of malignancy of pancreatic masses. |
Keywords : colorectal cancer, pancreatic cancer, liver metastatasis, glucose metabolism, [
18F]-fluorodeoxyglucose, positron emission tomography |
|
